Titin function in the active sarcomere studied in frog muscle fibers upon inhibition of myosin motors by para-nitro-blebbistatin

Titin spans the whole half-sarcomere, through the I-band connecting the Z-line to the myosin filament tip, and through the A-band, associated to myosin filament, up to M-line. Titin in the I-band transmits the stress also without attached myosin motors and is responsible for the passive force developed when a skeletal muscle fibre is stretched at rest. However, the passive stiffness in the range of physiological sarcomere lengths (SL, <2.7 µm) is too low to account for a putative role of I-band titin as mechanical link able to sustain mechanosensing in myosin filaments and prevent development of sarcomere inhomogeneity during contraction. Here we define titin mechanics during tetanic stimulation of intact frog muscle fibers using 20 μM para-nitro-blebbistatin (which fully inhibits myosin ATPase in vitro) to suppress the myosin-based mechanical responses. Small-angle X-ray fiber diffraction at the European Synchrotron ESRF demonstrates that the resting structure of thick filament is fully preserved upon tetanic stimulation. Under these conditions we use stepwise changes in force (10-50 pN per half-thick filament, htf) to elicit the lengthening transient that defines titin dynamic stiffness in situ at 2.3–3.0 µm SL. We show that, upon tetanic stimulation titin switches from the OFF-state characterised by a large, SL-dependent, extensibility, to the ON-state in which it opposes stretching with an effective stiffness one-two order of magnitude larger (∼3 pN·nm−1·htf−1) and independent of SL. The results demonstrate that, in the active sarcomere working at physiological lengths, I-band titin is an efficient mechanical link between the Z-line and the myosin filament tip, a condition for playing a role in mechanosensing-based myosin filament activation and for opposing to development of SL inhomogeneity during contraction. Supported by ECRF, University of Florence and MUR (Italy), ESRF (France) and EJP-RD.